Global Infectious Bursal Disease Vaccine Market Segment Research Report 2024
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Infectious Bursal Disease Vaccine Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Infectious Bursal Disease Vaccine industry at home and abroad, estimate the overall market scale of the Infectious Bursal Disease Vaccine industry and the market share of major countries, Infectious Bursal Disease Vaccine industry, and study and judge the downstream market demand of Infectious Bursal Disease Vaccine through systematic research, Analyze the competition pattern of Infectious Bursal Disease Vaccine, so as to help solve the pain points of various stakeholders in Infectious Bursal Disease Vaccine industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Infectious Bursal Disease Vaccine Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Infectious Bursal Disease Vaccine Market?
Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Plyco Bioengineering Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Major Type of Infectious Bursal Disease Vaccine Covered in XYZResearch report
Live
Inactivated
Application Segments Covered in XYZResearch Market
Veterinary Pharmacy
Online Sale
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global Infectious Bursal Disease Vaccine Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Infectious Bursal Disease Vaccine Market by Value
2.2.1 Global Infectious Bursal Disease Vaccine Revenue by Type
2.2.2 Global Infectious Bursal Disease Vaccine Market by Value (%)
2.3 Global Infectious Bursal Disease Vaccine Market by Production
2.3.1 Global Infectious Bursal Disease Vaccine Production by Type
2.3.2 Global Infectious Bursal Disease Vaccine Market by Production (%)
3. The Major Driver of Infectious Bursal Disease Vaccine Industry
3.1 Historical & Forecast Global Infectious Bursal Disease Vaccine Demand
3.2 Largest Application for Infectious Bursal Disease Vaccine (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Infectious Bursal Disease Vaccine Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Infectious Bursal Disease Vaccine Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Infectious Bursal Disease Vaccine Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Infectious Bursal Disease Vaccine Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Infectious Bursal Disease Vaccine Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Infectious Bursal Disease Vaccine Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Infectious Bursal Disease Vaccine Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Infectious Bursal Disease Vaccine Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Infectious Bursal Disease Vaccine Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Infectious Bursal Disease Vaccine Average Price Trend
12.1 Market Price for Each Type of Infectious Bursal Disease Vaccine in US (2018-2022)
12.2 Market Price for Each Type of Infectious Bursal Disease Vaccine in Europe (2018-2022)
12.3 Market Price for Each Type of Infectious Bursal Disease Vaccine in China (2018-2022)
12.4 Market Price for Each Type of Infectious Bursal Disease Vaccine in Japan (2018-2022)
12.5 Market Price for Each Type of Infectious Bursal Disease Vaccine in India (2018-2022)
12.6 Market Price for Each Type of Infectious Bursal Disease Vaccine in Korea (2018-2022)
12.7 Market Price for Each Type of Infectious Bursal Disease Vaccine in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Infectious Bursal Disease Vaccine Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Infectious Bursal Disease Vaccine
14. Infectious Bursal Disease Vaccine Competitive Landscape
14.1 Zoetis
14.1.1 Zoetis Company Profiles
14.1.2 Zoetis Product Introduction
14.1.3 Zoetis Infectious Bursal Disease Vaccine Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Merck
14.2.1 Merck Company Profiles
14.2.2 Merck Product Introduction
14.2.3 Merck Infectious Bursal Disease Vaccine Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Elanco
14.3.1 Elanco Company Profiles
14.3.2 Elanco Product Introduction
14.3.3 Elanco Infectious Bursal Disease Vaccine Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Boehringer Ingelheim
14.4.1 Boehringer Ingelheim Company Profiles
14.4.2 Boehringer Ingelheim Product Introduction
14.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Ceva
14.5.1 Ceva Company Profiles
14.5.2 Ceva Product Introduction
14.5.3 Ceva Infectious Bursal Disease Vaccine Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Qingdao Yibang Biological Engineering Co., Ltd.
14.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Profiles
14.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Product Introduction
14.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Shandong Lvdu Biological Technology Co., Ltd.
14.7.1 Shandong Lvdu Biological Technology Co., Ltd. Company Profiles
14.7.2 Shandong Lvdu Biological Technology Co., Ltd. Product Introduction
14.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Plyco Bioengineering Co., Ltd.
14.8.1 Plyco Bioengineering Co., Ltd. Company Profiles
14.8.2 Plyco Bioengineering Co., Ltd. Product Introduction
14.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Ruipu Biopharmaceutical Co., Ltd.
14.9.1 Ruipu Biopharmaceutical Co., Ltd. Company Profiles
14.9.2 Ruipu Biopharmaceutical Co., Ltd. Product Introduction
14.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
14.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Profiles
14.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Product Introduction
14.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source
List of Figure
List of Tables and Figures
Figure 1. Total Demand by Application of Infectious Bursal Disease Vaccine Industry (Volume)
Figure 2. Infectious Bursal Disease Vaccine Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Infectious Bursal Disease Vaccine Revenue in 2022
Figure 5. US Infectious Bursal Disease Vaccine Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Infectious Bursal Disease Vaccine Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Infectious Bursal Disease Vaccine Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Infectious Bursal Disease Vaccine Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Infectious Bursal Disease Vaccine Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Infectious Bursal Disease Vaccine Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Infectious Bursal Disease Vaccine Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Infectious Bursal Disease Vaccine Revenue, by Type (Million USD) (2018-2028)
Table 4. Infectious Bursal Disease Vaccine Production, by Type (K Unit) (2018-2028)
Table 5. Infectious Bursal Disease Vaccine Demand (K Unit) by Application (2018-2028)
Table 6. Infectious Bursal Disease Vaccine Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Infectious Bursal Disease Vaccine Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Infectious Bursal Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Infectious Bursal Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Infectious Bursal Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Infectious Bursal Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Infectious Bursal Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Infectious Bursal Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Infectious Bursal Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Infectious Bursal Disease Vaccine in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Infectious Bursal Disease Vaccine in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Infectious Bursal Disease Vaccine in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Infectious Bursal Disease Vaccine in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Infectious Bursal Disease Vaccine in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Infectious Bursal Disease Vaccine in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Infectious Bursal Disease Vaccine in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Zoetis Profiles
Table 61. Zoetis Infectious Bursal Disease Vaccine Product Introduction
Table 62. Zoetis Infectious Bursal Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Zoetis Strategic initiatives
Table 64. Merck Profiles
Table 65. Merck Infectious Bursal Disease Vaccine Product Introduction
Table 66. Merck Infectious Bursal Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Merck Strategic initiatives
Table 68. Elanco Profiles
Table 69. Elanco Infectious Bursal Disease Vaccine Product Introduction
Table 70. Elanco Infectious Bursal Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Elanco Strategic initiatives
Table 72. Boehringer Ingelheim Profiles
Table 73. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Introduction
Table 74. Boehringer Ingelheim Infectious Bursal Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Boehringer Ingelheim Strategic initiatives
Table 76. Ceva Profiles
Table 77. Ceva Infectious Bursal Disease Vaccine Product Introduction
Table 78. Ceva Infectious Bursal Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Ceva Strategic initiatives
Table 80. Qingdao Yibang Biological Engineering Co., Ltd. Profiles
Table 81. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Introduction
Table 82. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Qingdao Yibang Biological Engineering Co., Ltd. Strategic initiatives
Table 84. Shandong Lvdu Biological Technology Co., Ltd. Profiles
Table 85. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Introduction
Table 86. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Shandong Lvdu Biological Technology Co., Ltd. Strategic initiatives
Table 88. Plyco Bioengineering Co., Ltd. Profiles
Table 89. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Introduction
Table 90. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Plyco Bioengineering Co., Ltd. Strategic initiatives
Table 92. Ruipu Biopharmaceutical Co., Ltd. Profiles
Table 93. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Introduction
Table 94. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Ruipu Biopharmaceutical Co., Ltd. Strategic initiatives
Table 97. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Profiles
Table 98. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Introduction
Table 99. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Strategic initiatives
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices